AI Terminal
Carl Zeiss Meditec AG
Earnings Release • Oct 2, 2019
74_rns_2019-10-02_64b2c801-fd6a-4f68-a1d5-0bee9de39df9.html
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 2 October 2019 09:13
Carl Zeiss Meditec AG achieves significant growth in revenue and profit in fiscal year 2018/19
Carl Zeiss Meditec AG / Key word(s): Annual Results
Carl Zeiss Meditec AG achieves significant growth in revenue and profit in fiscal year 2018/19
02-Oct-2019 / 09:13 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
| Carl Zeiss Meditec AG achieves significant growth in revenue and profit in fiscal year 2018/19 |
| Jena, October 2, 2019 Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of approximately EUR 1,459 million in fiscal year 2018/19 (PY: EUR 1,280.9 million), based on preliminary data, and has thereby significantly exceeded the previous forecast of EUR 1,350 to EUR 1,420 million. This corresponds to revenue growth of approximately 13.9% vs. the previous year’s value. After adjustment for currency effects [1] , growth amounts to around 11.9 %. From today’s point of view, the company expects a strong increase in operating earnings [2] (EBIT) and anticipates to significantly exceed the previous forecast of an EBIT margin [3] between 15.0% to 17.5% (PY: 15.4%) as well as current market expectations estimated at around 18.5%. Full results for business year 2018/19 will be provided on Dec 6, 2019. As already reported after nine months 2018/19, management expects no further sustainable increase in EBIT margin in fiscal year 2019/20, partly due to planned strategic investments in research and development. |
Contact for investors and press
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: [email protected]
[1] Currency-adjusted sales growth is determined by weighing sales in the comparative period with current instead of actual historical exchange rates.
[2] Earnings before interest and taxes (also operating profit, EBIT) refers to a key earnings figure within the Carl Zeiss Meditec Group and is calculated in accordance with IFRS standards (see Annual Report 2017/18, p. 76 for reconciliation).
[3] Calculation: EBIT margin = EBIT / revenue (in %) (see Annual Report 2017/18, p. 76).
02-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Carl Zeiss Meditec AG |
| Göschwitzer Str. 51-52 | |
| 07745 Jena | |
| Germany | |
| Phone: | +49 (0)3641 220-0 |
| Fax: | +49 (0)3641 220-112 |
| E-mail: | [email protected] |
| Internet: | www.zeiss.de/meditec-ag/ir |
| ISIN: | DE0005313704 |
| WKN: | 531370 |
| Indices: | MDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 884075 |
| End of Announcement | DGAP News Service |